How These College Interns Are Saving Lives and Breaking Records with Be The Match
![Be The Match - National Marrow Donor Program](https://nationalstemcelltherapy.com/wp-content/uploads/2023/05/Be-The-Match-National-Marrow-Donor-Program-1024x278.png)
Be The Match, the organization behind the world’s most diverse registry of blood stem cell and marrow donors, announced that the William G. Pomeroy Foundation has granted them an additional $300,000. This generous contribution will allow the organization to further diversify the Be The Match Registry by expanding its presence at historically Black colleges and […]
Beam Therapeutics Enrolls First Patient in BEACON Clinical Trial of BEAM-101 Base Editing Therapy Candidate for the Treatment of Sickle Cell Disease
![Beam Therapeutics logo](https://nationalstemcelltherapy.com/wp-content/uploads/2022/11/beam-therapeutics-logo-1024x525.jpg)
CAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the first patient has been enrolled in the company’s BEACON trial. BEACON is an open-label, single-arm, multicenter, Phase 1/2 clinical trial designed to evaluate the safety and efficacy of BEAM-101 in […]